Companies that make rubella vaccines have been getting harder and harder to come by. The global production of the rubella vaccine, supplied in combination with measles, mumps and varicell…
Wistar welcomes Dr. Noam Auslander as an assistant professor in the Cancer Center’s Molecular & Cellular Oncogenesis Program. She applies artificial intelligence (AI) through high-throughput co…
Dr. Hildegund Ertl, Wistar immunologist and vaccine developer, has been featured in local and national media and sought after by journalists as a source of expert opinions. A well-spoken scientist,…
Mice differ from people in many ways. But over the last decade, scientists have succeeded in engineering mice that are more humanlike in their ability to be infected with HIV, making it possible to…
Last February, Wistar welcomed the inaugural group of Cheyney University students enrolled in the biomedical research and training program co-developed in 2020 by the nation’s first biomedical rese…
Many people unwind in front of the television after a long day. But Noam Auslander, Ph.D., who joined The Wistar Institute Cancer Center in June as an assistant professor, often spends the evening …
Few biologists can say they saw a type of cells for the first time. Nan Zhang, Ph.D., who started at The Wistar Institute in September as an assistant professor, became one of those biologists when…
The Wistar Institute Board of Trustees approved the 2021-2026 Strategic Plan that will catalyze the Institute’s scientific excellence, innovation, and growth. The power of science has never been cl…
Building on educational efforts and a portfolio of education initiatives, Wistar has significantly invested in its mission to train future scientists. Whether through working with the state of Penn…
Scientists developed COVID-19 vaccines in record time — less than a year after the genome of the virus was sequenced, countries started authorizing use of multiple vaccines. But the virus is rapidl…
